2018.02.15
PeptiDream Announces Initiation of a Molecular Imaging Study in Discovery Alliance with Bristol-Myers Squibb
PeptiDream Inc., a Kanagawa-based biopharmaceutical company (“PeptiDream”) announced today the initiation of a Molecular Imaging study by its alliance partner, Bristol-Myers Squibb Company (BMS).
